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Szent-Gyorgyi (1) during his investigations of biological oxidation-
reduction systems isolated a crystalline substance, highly reducing in its
properties, from the ox adrenal gland, cabbage and orange. This substance
was acid in nature, optically active and gave the colour reactions charact¬
eristic of the sugars. He called this substance hexuronlc acid and suggest¬
ed the chemical formula G^HgC^. Tillaans (2) from his investigations on
vitamin C suggested the possible identity of vitamin C with hexuronic acid.
King and Waugh (3) and Svirbely and Szent-GySrgyi (4) showed that the cryst¬
alline substance hexuronic acid was antiscorbutic in the guinea pig. Szent-
Gydrgyi and Haworth (5) renamed hexuronic acid Ascorbic Acid. Harris and
Ray (6), Hirst and Zilva (7) confirmed the antiscorbutic property of ascorbic
acid.
Reichstein, Grttsaner and Oppenauer (8) and Ault, Baird, Garrington,
Haworth, Herbert, Hirst, Percivol, Smith and Stacey (9) synthesized ascorbic
acid in the laboratory from xylosone. Over the years our knowledge of
vitamin G lias grown and it is difficult to assess the importance of the
contributions of the many workers in the field.
Herbert, Hirst, Percival, Reynolds and Smith (10) i-jorked out the
structure and chemical properties of ascorbic acid on samples isolated from
natural sources by Szent-Gybrgyi before the synthesis of ascorbic acid was















In this detailed study of the chemistry, Herbert ot s^. showed that ascorbic
acid behaves as a weak organic acid and is very readily oxidized. The stages















































Herbert et a^. showed that the oxidation of ascorbic acid occurs in two well
defined stages. The first stage in the oxidation involved in effect the
addition of two hydroxy! groups to a double bond giving rise to a laydrated
product,/
->
product, neutral in character and behaving as a lactone of a monobasic
hydros acid. No disintegration of the molecule takes place during this
process as the product can be converted, readily and quantitatively, into
ascorbic acid by reducing agents such as hydrogen sulphide (7,11) or hydro-
iodic acid. This reversible dahydrogonated product dehydroascorbic acid
(DHA), when newly formed, loses the property of selective absorption charact¬
eristic of ascorbic acid, and when kept in aqueous solution at room temperat¬
ure it autarotates and the property of selective absorption reappears. The
product of tiie autarotation is 2:3-diketo-l-gulonic acid (DK&) and dehydro-
ascorbic acid is a lactone of 2:3-diketo-l-gulonic acid with two of its
carboxyl groups hydratod. Ascorbic acid itself is the reduced form of this
hydrated lactone. Herbert et oJ,. suggested that this transformation into
2s3-dikoto-l-gulonic acid involves tlie opening up of the lactone ring of the
ascorbic acid molecule and conversion into an open chain six carbon compound.
Prom 2i3-diketo-l-gulonic acid, reformation of ascorbic acid is possible,
vitro, under drastic treatment by lactonisation followed by reduction. When
2s3-dHceto-l-gulonic acid is oxidised the six carbon chain is broken down with
the formation of oxalic and 1-threonic acids.
L~Xyloascorbic acid, the only naturally occuring form of ascorbic acid,
so far known, is widely distributed in both the animal and plant kingdom. Man,
primates and guinea pigs need vitamin C supplements in their diets, to remain
free from the deficiency disease scurvy, which the lack of asoorbic acid
produces. Synthesis of ascorbic acid in the animal body does occur. In the
case of rats, for which ascorbic acid is not essential as a vitamin, when
stimulated/
stimulated to synthesize, by the administration of chloretone, they most
probably do so at the expense of glucose* King and his collaborators (12,
13,14), in tracer studies with glucoge-C^, have shown that I>-gluco3e is
almost certainly a precursor of ascorbic acid in the animal body. This
synthesis most probably takes place through the intermediate formation of
glucuronic acid. Isherwood, Chen and Mapson (15) in their extensive studies
on the synthesis of ascorbic acid in plants and animals have put forward
evidence to show that the sequence of events in the synthesis is probably as
follows :
(1) D-glucose > D-glucurono- / -lactone
> Ir-gulono- Y -lactone > L-ascorbic acid
(2) D—galactose > D-galacturonic acid methyl ester
> L-galactono- /-lactone > L-ascorbic acid
Eeid (16) summarises the functions of ascorbic acid, a3 known to-day, as
follows
1. "It regulates the colloidal condition of intercellular substances having
collagen or related substances as basic constituents. This is its most
definitely established function.
2. It protects hydrogen carriers, thereby preventing injurious oxidations
by acting as an antioxidant. An example of this type of action is to be
found in its relations with oc-tocopheroA.
3. It promotes certain types of oxidation such as that of fatty acids and
the production of the oxy type of adrenal cortical hormones (70).
4. It preserves a proper balance between different enzyme systems; the
oxidation/
oxidation-reduction potentials are th.U3 maintained at certain levels.
5. It plays a role in the formation of desoxyribo-nuclele acid, a substance
held to control the physical-chemical properties of the nuclei.
It is always tempting to the scientific mind to imagine an active
agent - vitamin, hormone or the like - as possessing a single fundamental
activity, no matter in how many superficial ways this may ultimately appear.
A list of activities such as that given above is, consequently, an indication
that the real mode of action of ascorbic acid is still unknown and that it
remains necessary to search for the common factor in these diverse manifest¬
ations. Not only is our ignorance of the physiological action of ascorbic
acid profound, our fundamental knowledge of its mode of disposal or destruction
in the animal body is also limited. Szent-GyBrgyl (17) showed the presence
of an enzyme, "ascorbic acid oxidase" capable of catalysing the direct oxidat¬
ion of ascorbio acid with molecular oxygen in the plant tissues. The counter¬
part of tills enzyme in the animal body 1ms so far eluded search. Enzymes
responsible for indirect catalysis of the oxidation of ascorbic acid to dehydro-
ascorbic acid have been demonstrated. Keilin and ilartreo (13) have shown that
ascorbic acid is rapidly oxidised by cytochrome oxidase along with cytochrome
c. Enzymes catalyzing the conversion of dehydroascorbic acid into diketogulonio
acid have not been demonstrs.ted 30 far, though the conversion is generally
accepted (19,20). Enzymes catalyzing the cleavage of the diketogulonic acid
molecule are, so far, not known.
Penney and Zilva (20) from their studies found that dehydroascorbic acid
tends to be converted to diketogulonic acid with comparative ease, both in the
presence/
presence and absence of oxygon, the rate being dependent on the pH of the
medium. At neutrality or at the normal pH of the tissues the conversion
was very rapid. Diketogulonic acid once formed cannot be reconverted in.
Use (19,a) and it was antiscorbutically inert. They considered the
possibility of the following pathway of metabolism
ASA ~—** DHA. > DMA
mentioning that under physiological conditions the concentration of de-
Iiydroaocorbic acid at any one time was very small and, in consequence,
the loss of ascorbic acid through tho conversion of dehydroaacorbic acid
into diketogulonic acid would be very small.
In the same year, Rosenfeld (22) questioned the transformation of
aehydroascorbic acid into the irreversible non-oxidative product diketo¬
gulonic acid in the degradation of ascorbic acid in the body. According
to him the dehydroascorbic acid was but a fraction of the total ascorbic
acid content of the living tissues, owing to the natural system for the
protection of this vitamin and the presence of excessive amounts of gluta¬
thione, The mechanism of degradation consisted first, in the formation of an
intramolecular stabilization product from dehydroaacorbic acid which, in the
presence of phosphate and at pH 7, was broken down quantitatively into
oxalic acid through a precursor possibly oxalyl threose.
Drnaron, Monier and Roe (23) have suggested that tho normal catabolism
of ascorbic acid does not take place solely through the conversion to de-
hydroascorbic acid and diketogulonic acid. On administration of large
doses, the catabolism may proceed along the pathway suggested by Penney and
Zilva/
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Zilva (20), Burns, Burch and King (24.), from a tracer study of the motab-
1
olism of ascorbic acid In the guinea pig with l-C^-l-ascorbio acid, have
come to the conclusion that the conversion of ascorbic acid to C02 is a
main pathway in its metabolism. The excretion of large amounts of oxalates
in the urine of the animals in these experiments, indicated that oxalic
acid is an end product of the metabolism* Burns, Hoebach and Schuleriburg
(25), from their studies in the rat with labelled ascorbic acid, arrived
at similar conclusions with regard to the metabolic fate of ascorbic acid.
Monier and Weiss (26,27,28) have demonstrated an increased excretion
of dehydroascorbic acid and diketogulonic acid in albino rats under condit¬
ions of 3tress.
London and Chrystovski (29) observed increased excretion of urinary
oxalates in man on ingestion of four or more grams of ascorbic acid.
Clayton, McSwinney and Prunty (30), from their metabolic studies
with pure preparations of dehydroascorbic acid in man and guinea pigs,
found that dehydroascorbie acid on absorption into the system was partly
reduced to ascorbic acid and partly converted to oxidation products. The
amount oxidised could be recovered, as "Roe and Kuether" material, only
in part, a greater portion being lost a3 other oxidation products, they
argue, possibly oxalate and carbon dioxide.
The outstanding property of ascorbic acid is the relative ease with
which it may be reversibly oxidised. It can be reversibly oxidised by a
number of substances such as luilagens, charcoal (31), and benzoquinone.
The relation between the chemical and biological processes leading to the
oxidation/
oxidation of ascorbic acid has engaged the attention of many investigators.
Both copper and iron salts have been shown to catalyse the oxidation (32#
33) and the oxidative activity of many tissues may be ascribed to this
cause. The working out of the possible mechanism of copper catalysed oxid¬
ation by Weissberger and LuValle (34) with the postulation of a sondquinone
form, lends support to the view of the occurence of monodehydroascorbie
acid in the tissues. The question of the existence of this substance in
the tissues and its importance in metabolism remain to be settled. Other
substances such as haemoehromogens (35) wore shown to be good catalysts.
Stotz, Harrer, Schultze and Sing (36) observed a slow oxidation of added
ascorbic acid by guinea pig liver brei and attributed this to the presence
of the cytochrome system. Giri (37) observed, with rat liver homogenates,
that the factors causing oxidation of ascorbic acid were present mostly in
the nuclear fraction whereas all the other fractions inhibited the oxidat¬
ion. As a link in the chain of this oxidation-reduction reaction the
presence of deh/droascorbic acid in the tissues appears to be a possibility.
Kinsey (33) confirmed the presence of about 3 zg/lQO ml. of dehydroascorbic
acid in the normal aqueous humour of the rabbit. Stewart, Horn and Robson
(39) obtained evidence for the presence of significant amounts of dehydrat¬
aseorbie acid in human plasma.
Szent-Gyiirgyi (l) showed that in minced rat kidney reversibly oxid¬
ised hexuronic acid could be reduced by fixod -SH and glutathione. Hopkins
and Morgan (40) followed this up with quantitative experiments and observed
that when glutathione and ascorbic acid were together in the presence of
ascorbic/
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aseorbic acid oxidase, glutathione itself underwent oxidation thus sparing
ascorbic acid. They observed the reduction of dehydroascorblc acid by
glutathione a3 well, but noted tlxat it wa3 a slow process. Borsook,
Davenport, Jeffreys and Warner (19) showed that dohydroascorbic acid added
to minced or intact tissues from rats v;as rapidly reduced and concluded
that the reducing mechanism possibly involved glutathione and fixed -SH
groups. They did not find any evidence for ensymic reduction. The reduct¬
ion of dehydroascorbic acid by slices or sections of surviving scorbutic
guinea pig tissue was demonstrated by them. Schultae, Stotz and King (41)
observed, with guinea pig tissues, that dehydroascorbic acid was reduced
by a number of tissues, liver, muscle, small intestine, blood and erythro¬
cytes. They noted an increased capacity far reduction after heat coagul¬
ation in the liver, muscle, whole blood and red cells. Blood plasma,
heated or unheated, failed to reduce dehydroascorbic acid. Addition of
iodoacetato, arsenito or alloxan inhibited the reduction completely. They
concluded that glutathione and fixed -SH compounds of tissues are responsible
for the reduction of added dehydroascorbic acid and denied the existence of
any enzymic reduction. They suggoated that the reduction of dehydroascorbic
acid by animal tissues depends greatly upon the participants in the revers¬
ible reaction
dehydroascorbic acid + 2 -SH v "** ascorbic acid + -S-S.
This, as an enzyaic reaction, has not yet been demonstrated in animal tissue.
Recently, glutathione reductase, an enzyme catalysing the reduction of oxid¬
ised glutathione in the presence of dehydrocoenzyme II has been shorn to
exist/
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exist in plant tissues (42,43) and in the rat liver (44)« The enzyme
catalyzes the inaction
GSSG + TPNH2 > 2GSH + TPN,
the reverse of which could not be demonstrated. A possible scheme of
hydrogen transfer involving ascorbic acid, glutathione and coenzyme II in
animal tissues
GSSG + TPNH2 > 2GSH «■ TRi
Deh droascor'oic acid + 2GSII ascorbic acid + GSSG has been
considered. That such a system possibly exists is realised when we consider
that neither dehydroascorbic acid nor oxidised glutathione remain in the
tissues.
Johnson and Zilva (45) observed that when dehydroascorbic acid was
ingested in man, it appeared a3 reduced ascorbic acid in urine. Fox and
Levy (46) from their studies on the guinea pig confirmed the antiscorbutic
property of dehydroascorbic acid. They found that dehydroascorbic acid was
reduced to ascorbic acid which was stored to a small extent in the livers
of the experimental animals. Roe and Barnuia (47) made a quantitative study
of the physiological activity of dehydroascorbic acid when administered
orally or parenterally to guinea pigs. They could not detect any storage
of vitamin G either in the oxidised or in the reduced form in the tissues.
They found that dehydroascorbic acid wa3 reduced in the blood of guinea
pigs, rats and man and that this reduction was duo to an enzyme. Dehydro¬
ascorbic acid was much less potent in its antiscorbutic property than the
reduced form of the vitamin and this antiscorbutic property was due to the
enzymic/
•11-
ensymic reduction in blood,. Borsook et aL. (19) confirmed the antiscorbutic
property of dohydroaaeorbic acid. They found that, on ingestion of dehydro-
ascorbic acid, there was an increased concentration of ascorbic acid in
blood plasma and ascorbic acid was excreted in large quantities in the urine.
Dehydroascorbic acid was rapidly reduced in the tissues of the animal body.
Gould and Shwachman (48) in their investigations on methods of bio-
assay of antiscorbutic substances with guinea pigs concluded that the anti¬
scorbutic potency of dehydroascorbic acid was about 80 per cent activity of
the pure vitamin. Penney and Zilva (20), from their metabolic studies on
the guinea pig, observed that on administration of dehydroascorbic acid by
intramuscular injection it was partly reduced by the organism to ascorbic
acid and partly converted to diketogulonic acid. The ascorbic acid entered
the tissues. Diketogulonic acid was mainly excreted in the urine. They
suggested that when largo quantities of dehydroascorbic acid are introduced
into the circulation it i3 mainly reduced in the liver. When ingested,
dehydroascorbic acid remained stable and stationary for sometime in the
stomach before being gradually absorbed. It was reduced to ascorbic acid
in tire tissues of the stomach while being absorbed as shown by the increased
concentration of ascorbic acid. The dehydroascorbic acid that escaped into
the small intestine was converted to diketogulonic acid owing to the alkal¬
ine condition of the medium. Todhunter, McMillan and Ehmke (4-9), in their
investigations on the extent of utilisation of dehydroascorbic acid in the
human system, came to the conclusion that when dehydroascorbic acid wa3
ingested, the levels of reduced ascorbic acid in the blood serum and urine
were/
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were comparable to those obtained when the reduced form of the vitamin was
taken, indicating satisfactory utilisation. They found no consistent
evidence for the presence of dehydroascorbic acid in blood or urine follow¬
ing the ingestion.
Langham (50) has shown that, in the rabbit, intravenous administrat¬
ion of dehydroascorbic acid leads to a greater concentration of the reduced
form in the aqueous humour, than that obtained on administration of ascorbic
acid by the same route. He suggests that the increased accumulation of
ascorbic acid in the aqueous humour involved the reduction of dehydroascorbic
acid by the lens and other intraocular structures. Whereas in the cat, he
found, that on intravenous administration, dehydroascorbic acid or ascorbic
acid appeared to pass into the eye at the same and a much slower rate.
Kinsey (33) ob.served that dehydroascorbic acid was reduced by solutions of
glutathione or crushed lenses but not by intact lenses in solution or in
eyes which had been removed. He found that the injection of dehydroascorbic
acid into the posterior chamber did not lead to any increase of ascorbic
acid content in the anterior chamber. He confirmed the findings of Langham
In the rabbit following intravenous administration of dehydroascorbic acid
but explained it on the basi3 of the rise in concentration of ascorbic acid
in blood plasma.
Patterson and Ma3tin (51) reported that ten minutes after an intra¬
venous injection of dehydroascorbic acid, the ascorbic acid level in the
rat brain was markedly raised from a rapid intracellular reduction of de¬
hydroascorbic acid in the brain. A dose of 200 ag/Kg. DHA given intra¬
venously/
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venously in the rat more than doubled the ascorbic acid content of the
brain, whereas the administration of a similar dose of ascorbic acid
did not affect the ascorbic acid level. With repeated doses of dehydro-
ascorbic acid the level of ascorbic acid in the brain tends to rise but
the increase becomes progressively smaller due to the accumulation of
ascorbic acid from reduction.
In man, Matnsis (52) found the capacity to reduce dehydroascorbic
acid to ascorbic acid was greatest in the liver. The other organs in order
of their capacity to reduce are the kidney, adrenal, pancreas and intestine.
This capacity i3 diminished in certain of the organs of people dying of
prolonged illnesses, while the pancreas and adrenals retained it to the
full. Similar reduced capacities wore observed in the organs of scorbutic
or tuberculous guinea pigs, white rats in experimental intestinal obstruct¬
ion and white mice after clironic poisoning with neoarsphonamine.
Dararon, Monier and Roe (23), in their metabolic study could recover
as ascorbic acid 38 t 16 per cent alter one hour and 33 1 20 per cent after
two hours, the injected dose being approximately 25 tag/Kg. body weight of
dehydroascorbic acid given in young guinea pigs. Of this dose, 19 - 15 per
cent and 8.3 + 14 per cent were recovered as DUA while 18 1 9 por cent and
9.5 1 1.6 per cent were converted to DKA after the same intervals.
Following the isolation of dehydroascorbic acid and its derivatives
by Senyon and ikmro (53) and by Pecherer (54-) in the solid state, de Ritter,
Cohen and Rubin (55), from their investigations on the physiological avail¬
ability on ingestion in man, concluded that dehydroascorbic acid and dehydro¬
ascorbic/
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ascorbic acid isethaaolate ware well utilised. They did not find any de-
hydroascorbic acid in the urine following ingestion.
Panteleeva (56) observed that in vitro under physiological conditions
of pH and temperature dehyiroascorbic acid rapidly diffuses into human ery¬
throcytes, the speed of this diffusion is much greater than that of ascorbic
acid. Dehydroascorbic acid diffuses also into the erytlirocytes in blood
from the horse, cat, rabbit, dog and goose, but at a slower rate. It is
partially reduced inside the red corpuscles to ascorbic acid and he suggest¬
ed that the movement of ascorbic acid between erythrocytes and the plasma
occurs in the form of dehydroascorbic acid. Lloyd (57) reported intracellular
reduction in erythrocytes of dehydroascorbic acid added to defibrinated human
blood. Lloyd and Parry (53) have estimated the capacity of human eryfclirooytes
for reducing dehydroascorbic acid and suggest that the rate of reduction of
DHA to ASA is similar to the rate of transformation of DliA to DKA» From their
attempts to establish a coiling level of reduced ASA in erythrocytes they
suggest that the power of erythrocytes to reduce DHA is "limited by kinetic
rather than by stoichiometric factors".
Bhattacharya (59) has shown that dehydroascorbic acid undergoes reduct¬
ion in the erythrocytes of the rabbit, both in vitro and in vivo. A consid¬
erable amount of the dehydroascorbic acid appears to be converted to diketo-
gulonic acid. He has concluded that glutathione is not responsible for the
reduction of dehylroascorbic acid in rabbit blood. Ho has shown, along with
the reduction of dehydroascorbic acid to ascorbic acid, in the rat liver
there i3 a fall in the glutathione level. He suggests that glutathione is
responsible/
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responsible for this reduction.
Dehy&roascorbic acid bears a close resemblance in structure and
properties to alloxan, and Patterson understood the significance. Patter¬
son demonstrated the diabetogenic action of deliydroascorbic acid in albino
rats when injected intravenously with large doses (6o). Dehydroisoascorbic
acid (61) and dehydroglucoascorbic acid were shown to be diabetogenic while
diketogulonic acid was not (62). The diabetes following dehydroascorbic
acid injections is permanent and may lead to cataracts in the albino rats
(63). Patterson and Mastin (51) showed some effects on the central nervous
system on injection of dehydroascorbic acid into albino rats. Patterson
and Lasarow (64) demonstrated that glutathione, cysteine and 2s3-dimercapto
propanol (BAL) administered intravenously immediately before the intravenous
injection of dohydroascorbic acid in diabetogenic doses prevented the onset
of diabetes. Similar prevention results from previous injection of atropine
(65) although atropine injected into splenectomised rats did not have any
preventive action. Bilateral adrenalectomy in DHA-induced diabetic rats
ameliorates the condition (66).
Merlini (67) did not confirm the diabetogenic action of dehydro¬
ascorbic acid in rats. Princlotto (68) produced diabetes in fasting rabbits
by intravenous injection of dehydroaocorbic acid in four equal doses totall¬
ing 0.6 g/Kg. given at fifteen minute intervals, while Banerjee, Belavady
and Muliherjee (69) failed to confirm, the diabetogenic action of dehydro-
ascorbie acid in rabbits. They reported that intravenous injection of de-
hydroaseorbic acid in doses of 1 g/Kg, failed to produce persistent hyper¬
glycemia/
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glyoaemia or a diabetic type of glucose tolerance curve. Bhattacharya (59)
confirmed the diabetogenic effect of dehydroascorbic acid in albino rata
but not in rabbits.
To gain an insight into the metabolism of dehydroascorbic acid when
administered intravenously into the albino rat vr\ diabetogenic doses,work
was undertaken and the observations made on the tissue levels of ascorbic
acid following the injections are reported here.
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EXEmiMEKI'AL
llatorisls. 4. Ascorbio acid - Roche Products, Ltd.
lletaphosphoric Acid. Reagent grade, B.D.H.
216 dicliloropIienol_indophenol, B.D.H.
Sodium Citrate, A.R., B.D.H.
Trichloracetic Acid, A.R., B.D.H.
Norit Charcoal, acid washed before use.
2s4 dinitrophenylhydrazine, A.R., B.D.H.
Thiourea, Reagent grade, B.D.H.
Quinone, Commercial, B.D.H. Resublimed before use.
Nembutal (Pentobarbitone Sodium, B.P.) Abbot Laboratories,
Ltd.
Spectrophotometer, Unioam SP 600.
Young healthy V/istar Glaxo albino rats of both sexes,
within the range of body weight (varying) from 130 g.
to 200 g. were used in the experiments. The animals
were inbred in the laboratory and were maintained on
rat cubo3 and water ad libitum. Tho composition of
the rat cubes was as follows 1-
Fino bran - 17.4& ground maize - 17.4$, ground Sussex
oats - 17.4$» ground barley - 17.4$, white fish meal -
4.6%, meat and bone meal - 9,6%, dried skimmed milk -






The experiments consisted in the determinations of ascorbic acid
and total ascorbic acid (ASA + DHA + DKA) in the tissues and blood, before
and after the inject ions of dehydroascorbic acid.
Tissues were obtained by sacrifice of the animals by stunning or
under nembutal anaesthesia. The abdomen was opened up and the animal was
bled from trie abdominal aorta as completely as possible, the blood being
collected in a heparinised syringe. The tissues, in requisite amounts,
were successively removed, freed from adherent tissue, wiped dry on a
filter paper and immediately immersed in 5 - 10 volumes of aqueous solution
of metaphosphoric acid or tricliloracotic acid contained in previously
weighed vessels. The aqueous solutions of 3% (w/v) metaphosphorlc acid
and l& (w/v) trichloracetic acid were prepared fresh on the day of the
experiment and used as protein precipitating and extracting agents for
ascorbic acid and total ascorbic acid respectively. The process of removal
of tissues was speedily completed and did not take longer than 10 minutes.
The weights of the tissues were found by the difference to the nearest milli¬
gram by weighing on a chemical balance. The weights of the 3uprarenals was
obtained by removing them from the extracting media. They were wiped dry
and the weights to the nearest milligram were found on a torsion balance.
Following this the tissues were ground with a pestle in a glass mortar under
the respective extracting solution with acid washed white sand till they
were completely pulped. More of the extracting agents were run in and the
extracts removed to volumetric flasks. Repeated rinsings were made to ensure
complete/
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coaplete transfer of the ground tissue. Volumes were made up in such a way
that the final concentration of ASA etc. in the extracts were near the middle
of the calibration ranges (5 - 10 T ). The contents of the flasks were
thoroughly shaken and centrifuged for 15 minutes at 2000 r.p.rn. The clear
supernatants wore decanted off for further processing.
Estimations of ascorbic acid in the tissue extracts were made by the
indophenol method described by Stewart, Horn and Robson (39). The principles
on which the method is based are as follows:-
Ascorbic acid is the principal or perhaps the only substance, in acid extracts
of tissues, that reduces the dye 2t6 diclilorophenolindophenol to a colourless
compound at a pH of 1 to 4 within a period of 30 seconds. For the purposes
of this extraction, metaphosphoric acid is the reagent of choice. The amount
of ascorbic acid is proportional to the degree of reduction of the dye.
Under the specified conditions, interference frora other 3Ubstance3 that
reduce the dye, such as sulphydryl compounds etc., is minimum. In practice,
an excess of the dye in aqueous solution, freshly made, is allowed to be
reduced by a measured volume of the aetaphosphoric acid extract of tissue
and at the end of 3d seconds the degree of reduction is determined photo¬
metrically. With each experiment a calibration curve was run simultaneously.
Appropriate standards containing 1,2,4,6 and 3 V of ascorbic acid per ml. in
metaphosphoric acid as used for the tissues, were prepared and carried
through the entire procedure as the test solutions. The photometric densit¬
ies were plotted and a calibration curve obtained.
During tbo course of the experiments certain anomalies in the results
were/
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were noted. The values for total ascorbic acid determined were sometimes
lower than the values of ascorbic acid obtained by the indophenol method.
To find out whether sulphydryl compounds were interfering in these estimat¬
ions, experiments were made with the p-chloromercuribenzoic acid metiiod
recently reported by Owen, Iggo and Horn (71). The trial experiments with
chloromercuribenzoic acid were performed with the metaphosphoric acid extracts
of tissues and the standard solutions of ascorbic acid prepared for use in
the indophenol method. Along with these estimations in the indophenol method,
estimations of total ascorbic acid by the Roe and Kuether method (vide infra)
were done in two cases. Chloromercuribenzoic acid solution was prepared as
directed and 1 ml. of this solution was added to 4- nil. of the metaphosphoric
acid extract and processed. For a set of blanks, aetaphosphoric acid extracts
were also treated similarly with 0.Q5N. iiaOH solution used for dissolving the
chloromercuribenzoic acid. Standard curves with chloromercuribenzoic acid-
treated standard solutions and alkali-treated standard solutions of ascorbic
acid were run simultaneously with each experiment and values were read off the
respective curves. The results of these experiments are presented in Table A.
From Table A it will be observed that in the case of the liver the
values with chloroaercuribenzoic acid tend to be variable, in the kidneys they
tend to be lower and in the suprarenal and spleen they tend to be higher, with¬
in limits of experimental error. But the simultaneous estimations of total
ascorbic acid with Roe and Kuether method gave values for the kidney which were




Concentrations of ascorbic acid in the tissues obtained before and after
treatment of the tissue extracts with p-chloromerouribenzoic acid (CMB)»
expressed as mg. per 100 g. tissue
Tissue Indophanol method Indophenol method
with unbuffered with buffered Extract Extract Total Ascorbic
extract extract treated treated acid
with CI© with Roe & Kuether
alkali method
(Control)
Liver 21.5 23.1 22*4
19.3 » ... « < 20.5 21.3 19.2
30.2 25.5 30.4 29.3
25.6 24.3 25.4 26.1
Kidney 9.0 3.5 3.3
9.5 3,3 11.2 3.7
12.4 9.2 11.5 11.9
12.1 10.4 12,0 13.3
Supra¬ 400.0 460.0 495.0







31.0 30.2 31.3 31.3
The results wero inconclusive so far as these anomalies in the ASA
i
and TASA values xrero concerned. Mindlin and Butler (72) recommended a pH
of 4-1 for tiie final reaction mixture with indoplienol and motaphosphoric
acid extract. Bessey (73) suggested a pH of 3.5 approximately for tiie
reaction. Between pH 3 to 4 the indophenol fades least and the reaction
becomes more specific. So test experiments with buffered extracts were
made. In the case of the kidneys the values obtained with buffered extracts
were almost always lower than tnose obtained with unbuffered extracts. For
the purposes of the experiments, the metaphosphoric acid extracts were
buffered to a pH of 3.5 to 4 with a fresh solution of sodium citrate of
suitable concentration. A separate calibration curve with buffered solutions
of ASA in metaphosphoric acid, in the range of concentrations mentioned
above was run simultaneously with the test solutions on each day of exper¬
iment. The estimations for ascorbic acid in the tie ues wero completed with¬
in 6 hours after removal of the tissues every day. .
Estimations of total ascorbic acid were made with the method described
by Roe and Kuether (74). The principles underlying this method are as follows.
Ascorbic acid is oxidised to dohydroascorbic acid with a mild oxidising agent.
Dehydroascorbic acid undergoes spontaneous transformation into diketogulonic
acid in mildly acid solution. When treated with 2j 4—dinitrophenylhydrazine,
DHA and DKA form a derivative, a bis-2; 4-diniorophenylhydrasono. The rate
of coupling of 2:4-dinitrophenylhydrasine with DKA is faster than with DHA
and possibly DHA is converted to DKA before coupling takes place. When the
bis-2:4-dinitropheyiylhydrazone so formed, is treated with 35% sulphuric acid,
-23-
a highly stable reddish brown product is formed which is soluble in the
acid. This solution absorbs maximally at about 54) tup. The colour obtain¬
ed in this x-ray is measured photometrically, the intensity being proportional
to the total ascorbic acid originally present. The coupling reaction is
carried out in a medium containing reducing agents, e.g. thiourea, to avoid
interference from non-ascorbic acid chroaogens.
A standard curve was prepared on each day of the experiment in the
following way. Appropriate standard solutions of ascorbic acid, in concen¬
trations ranging from 0.625 to 5 Vper ml., were made up in U per cent
(w/v) trichloracetic acid as used for the extraction. These were run,
along with the test solutions, through the entire procedure. From the
photometric densities a standard curve was obtained and the values for the
test solutions were read off the curve.
The pancreas in the rat is a very diffuse gland intimately bound up
with omentum and other tissues. Preliminary trials with estimations far
ASA and TASA in two different extracting agents, namely met&phosphoric acid
and trichloracetic acid, gave values which were widely different. Proper
distribution of the true glandular tissue, in two different precipitants,
from the same gland removed at dissection is almost an impossibility. To
avoid this random distribution and the consequent errors, the gland, when
removed, was always immediately put in metaphosphoric acid only, and extracted.
The choice of metaphosphoric acid as the extracting agent 'was made
for the following reasons. Estimations of ascorbic acid in trichloracetic
acid with indophenol are erroneous owing to the fact that a certain amount
of/
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of oxidation of ascorbic acid takes place. The rate of fading of indophenol
solution in the presence of trichloi-acetic acid is more rapid than that in
the presence of aotaphoophoric acid (39). Experiments uitk mixtures of meta-
phosphoric acid and trichloracetic acid showed that the mixture decolourised
indophonol much more rapidly than did raetaphoaphoric acid alone as will be
evident from Fig, 1.
Preliminary trials with the adoption of the mixture of metaphospheric
acid and trichloracetic acid, in place of trichloracetic acid, in the Roe and
Kuether procedure showed that almost identical calibration curves and compar¬
able values could be obtained as in the original method, as shown in Fig. II.
Two sets of standard solutions of ascorbic acid in trichloracetic acid and in
a mixture of metaphosphoric acid-tricliloracetic acid were prepared and subject¬
ed to the same procedure simultaneously. The data obtained were plotted in
the same figure. The slopes of the curves are almost identical. For the
purposes of ticse experiments, 5 part3 of 3% (w/v) raetaphoaphoric acid extract
of pancreas were mixed with 3 parts of 6% (w/v) trichloracetic acid and the
mixture was subjected to the analytical procedure of Roe and Kuether and run
along with the other test solutions. Separate calibration curves were not
made, the values being read off the curve for the original method.
The problem of the ascorbic acid values exceeding those of the total
ascorbio acid, in some of the estimations, was considered from a different
angle. Anatomical differences in the representative samples of tissues in
two dissimilar extracting agents and the repeated weighings thereof may intro¬
duce errors in the estimated values. To avoid tiiis source of error, estimat¬
ions/
Fig. 1.
The effect of time on the density at 4<30 mp. of 1.0 ml. of the
indophenol solution (4 rag/,lOO ml.) in tho presence of 2.0 ml. of
standard ascorbic acid solutions (2, 4 and 6 "f per ml. from above
downwards). Initial reading taken at 30 seconds. • • , standard
ascorbic acid solutions in 3% (w/v) metaphosphoric acid; © © ,
standard ascorbic acid solutions in the :aixfcure of 3% (w/sr) aeta-
phosphoric acid and 6% (u/v) triciiloraoetic acid.
Standard curves obtained in the original and modified
Roe and Kuether methods. The dots represent the densities
obtained in the original method* The crosses represent
the densities obtained by the use of the mixture of 3%
(w/v) metaphosphoric acid and 6% (w/v) trichloracetic acid.
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ions of total ascorbic acid wore made in some cases with no taphosphoric acid
extracts, prepared for the estimation of ascorbic acid. In these estimations
the technique proposed by Bolin and Book (75) was followed. The principles
on which the method is based are as follows. Quantitative oxidation of
ascorbic acid in metaphoaphoric acid extracts of tissues is brought about by
the use of a strong solution of 2 s6-diclilorophenol^jsidophenol. The colour
due to the excess of dye is destroyed by thiourea subsequently. The oxid¬
ised ascorbic acid is treated with 2:4-dinitrophenylhydrasiie and a bio-2:4-
dinitrophenyihydrozone is formed. On treatment 'with &5% sulphuric acid this
gives a reddish brown colour which is measured photometrically at 540
The density of the colour produced is proportional to the total ascorbic acid
originally present. Standard curves, for this method, were again prepared on
each day of the experiment. Standard solutions of ascorbic acid in 3% (w/v)
metaphosphoric acid, in the concentration range of 1 to SYper ml., as made up
for the estimation of ascorbic acid by the indophenol method, were used. These
were treated in the same way a3 the test solutions.
Recovery Studies.
Recoveries of ascorbic acid added to the tissue extracts were made.
The addition of ascorbic acid was done in two different ways. In the first
group, 1 mg/lOO ml. ascorbic acid was dissolved in 3% (w/v) metaphosphoric
acid or 4$ (w/v) trichloracetic acid and the tissues were extracted with these
enriched media. In the other group 1 mg/LOO ml. ascorbic acid was dissolved
in the tissue extracts of metaphosphoric acid or trichloracetic acid. The
results of recoveries from these samples are presented in Table B.
Pros/
Tablo B.




















Total ASA (A) Roe &
Kuether
Total ASA(B) Roe &
Kuother
Total ASA(A) Bolin &
Book










ASA(A) ... ascorbic acid added to the precipitating agent
ASA(B) ... ascorbic acid added to the tissue extract.
»25~
Proa Table B it will be noted that in the case of the liver, the
recoveries of ascorbic acid added to the metaphosphoric acid before extract¬
ing the tissue were 93% and 9&.1% (mean) respectively, using buffered and
unbuffered extracts in the indophenol method. 93.3% (mean), of that added
to the extract, was recovered using unbuffered test solutions. Recoveries
as total ascorbic acid of the ascorbic acid added before extraction were 96%
(mean) by the Roe and Kuether method, and, of that added after extracting,
were 93.3% by the 'Roe and Kuether' raethod and 37% by the 'Bolin and Book'
method.
In the case of the kidney, the recovery of ascorbic acid added to the
extractant before precipitation was 35% (moan) a3 ascorbic acid using un¬
buffered samples in the method. Of that added after extraction 99% was
recovered as ascorbic acid lay using buffered test solutions in the method,
and 96.5% and 99% as total ascorbic acid by the 'Roe and Kuether' and 'Bolin
and Book' methods respectively.
Using extracts of the suprarenal glands, to which ascorbic acid was
added, the recoveries in the indophenol method were 99% (without buffering
the extract) and 100% (with buffered extract), while in the 'Bolin and Book'
method it was 104.5%.
When extracts of the spleen were U3©d, to which the ascorbic acid was
added, 102% was recovered as ascorbic acid in unbuffered samples and 100% as
total ascorbic acid in the Roe and Kuether method.
Experiments with dehvdroascorbic acid
Observations were made on the tissue levels of ascorbic acid following
the/
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the Intravenous injections of dehydroaacorbic acid to the albino rats and
as a preliminary to this study the levels of ascorbic acid in the tissues
of the control animals of both sexes were obtained. These animals were
not treated in any way and were sacrificed by stunning.
Patterson has produced hyporglycaeraia and diabetes in the albino
rats by using various dose levels of dehydroascorbic acid in his investig¬
ations. Following their investigations on sulphydryl protection against
the diabetogenic action of dehydroasaorbic acid, Patterson and Lasarow (64)
reported that a preliminary desensitising dose of 0.2 g/Kg. followed by a
dose of 0.7 g/Kg. body weight of dehydroascorbic acid given intravenously
on three successive day3 produced diabetes in 37$ of the albino rats.
This dose level wa3 selected for the purpose of this investigation and
the following scheme was adopted for the study of the tissue levels of
ascorbic acid.
Plan of the Experiments.
A Establishment of the control values of ascorbic acid.
B DBA injection experiments
(a) DHA injection (Detoxicating dose followed by main dose)
... removal of tissues after 15 minutes interval.
(b) DHA injection (Detoxicating dose and main dose)
... removal of tissues after an interval of 24 hrs.
(c) DHA injection {Detoxicating dose and main dose) on the
first day.




... removal of tissues after an Interval of 24- his.
(d) DM injection (Detoxicating dose and main dose) on the
first day.
Main dose repeated on the second day.
Main do3e repeated on the third day.
... removal of tissues after an interval of 15 minutes.
(e) DM injection - same a3 in (d).
... removal of tissues after an interval of 3 days or
more.
Dehydroascorbic acid was prepared according to the method described by
Patterson (61). 1.03 g. of ascorbic acid was dissolved in 10 ml. of 0.9#
sodium chloride solution and shaken for 15 minutes with an equal volume of
an ethereal solution containing 0.66 g. of freshly sublimed quinone. The
dehydroascorbic acid solution was separated and washed five times with an
equal volume of ether. The excess ether was subsequently removed by suction
under a filter pump. The solution, so prepared, was assumed to contain
100 rag/ml. of deliydroascorbic acid. The solution is stable for more than
two hours at room temperature and is reducible (95 - 93 per cent) to ascorbic
acid by Hy3 at pH 3.5 and 37°C. It contains traces of hydroquinone as shown
by a positive te3t with Chloraaine T. The solution of dehydroascorbic acid
»
,
was prepared ffcesh on each day that the injections wore given and wa3 used
within one hour of preparation.
The injections of dehydroascorbic acid were given in the tail veins
of/
—2£>—
of the rats, after dilatation in warm water, with an all-glass 3yringe and
a 26 gauge needle. Prior to the injection the animals were starved for 12
to 24. hours. A preliminary desensitising dose of about 0.2 g/Kg. body
weight of DHA wo.3 given and within 10 to 30 minutes the main dose of 0.7
g/Kg. DHA was administered. The main dose was repeated on the second and
third day approximately at 24 hour intervals, when necessary without further
. 1
desensitising. In the acute experiments, the animals were bled from the
10th to 14th minute and the tissues were successively removed from the 15th
to 21st minute after the injection of the main dose and within 30 - 35
minutes after the initial desensitising dose.
i>e
In order to facilitate accurate timing of the removal of tissues and
the collection of blood from the abdominal aorta the DHA-injected animals
were sacrificed under nembutal anaesthesia. 6 rag/100 g. body weight of
nembutal was administered intraperitoneally for this purpose. In the acute
experiments with DHA (in groups (a) and (d) of the plan) the injection of
nembutal preceded that of the main dose of DHA. Control values of tissue
ascorbic acid under nembutal anaesthesia were also obtained.
As the solution of dehydorascorbic acid contains traces of hydro-
quinone, it was necessary to find out whether any change in the values of
ascorbic acid in the tissues or interference in the methods were being
caused by the U3© of the above solution. To simulate conditions control
animals were injected with a solution of hydroouinone prepared as follows.
0.66 g. of hydroquinone was dissolved in 10 ml* of ether /and .shaken with
10 ml. of 0.9% aodium chloride solution for fifteen minutes, as in the
method/
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method of preparation of DHA. The saline solution was separated and extract¬
ed five times with pure ether, the excess of ether was removed by suction
xinder a filter pump. The solution 30 obtained was used for intravenous
injection without further treatment. The solution was injected in the same
way as DHA on three successive days into control female rats. No apparent
interference or significant change in the values of ascorbic acid was noted,
so this was not repeated in the male control rata.
Estimations of blood sugar levels were done by the method of Hagedorn
and Jensen (76). The total ascorbic acid concentration of blood was deter¬
mined by the Roe and Kuether procedure (74). Soon after withdrawal, the
blood was precipitated in 6% (w/v) trichloracetic acid solution and processed
along with the tissue extracts in the above method.
Certain general observations on morbidity and mortality following the
injections of dehydroaacorbic acid are noted. The phenomena of "tachyphylaxis"
were rioted with varying degrees of severity in all the animals. After recovery
from the Immediate effects of the administration of DHA on the first day the
animals, generally, did not take any food and varying losses of weight were
observed. After the second dose weakness, dehydration and I033 of weight
became marked features. Some of the animals developed dysenteric symptoms.
The loss of weight in a group of 23 animals averaged 26.79 g. £ 4*5 g., while
in another group of 3 animals, weight loss did not take place. These animals
were not apparently ill. Following the third injection, the weight loss and
dehydration progressively increased and the animals passed into a critical
phase of illness for the next 2-4 days. The greatest mortality in the
animals/
-30-
aniaals occurred during this period in this series. Hyperglycemia was
present in some of the animals (present in 4- out of 5 tested). On recovery





The data obtained in the different experiments are presented in
the following pages. Tables 1 to 3 and 5 to 7 summarise the results
obtained in the different control groups of animals used in this invest¬
igation. The results obtained following the intravenous injections of
DHA are summarised in Tables 3 to 17. For descriptive purposes, the
values obtained by the indophenol methods are spoken of as "ASA values"
while those obtained by the Roe and Kuethor method and the Bolin and
Book method are designated "TASA values".
Tables 1 and 2 summarise the ASA and TASA concentrations in the
tissues and organs of the control animals of both sexe3. These animals
were not subjected to any injection and were sacrificed by stunning.
The ASA and TASA concentrations in the liver, kidney, suprarenal, pancreas
and spleen of sis male rats with a mean body weight of 163 S« (range 155
to 170 g.) are presented in Table 1.
It will be observed that the ASA values obtained by the indophenol
methods, using buffered and unbuffered tissue extracts, are not signific¬
antly different. Thus, using buffered extracts, the liver of the male
rat was found to contain 30.2 t 4.89 mg.ASA/100 g., the corresponding
figure for unbuffered solutions being 30.0 t 4-. 15 mg.ASA/100 g. In the
case of the kidneys the figures for buffered and unbuffered solutions
































Concentrations of ascorbic acid and total ascorbic acid in the tissues



















































































































Pancreas 11.0 11.6 13.3 .12.9
11 11.3 11.5 12.1 12.1
H 14.4 15.3 13.2 14.3
K U.6 U.6 12.3 11.6
II 11.6 11.4 12.3 12.0
M 13.4 13.3 14.7 13.2
Mean 12.3 £ 1.31.. 12.5 £ 1.57 .. 13.2 £ 0,93 .. 12.7
Spleen 29.5 ^.9 35.5 40.7
» If? 36.1 47.6H 33*6 34.1 39.3 42.3
15.7 20.3 30.1 33.7
u 26.9 26.2 34.6 39.5
27.316.91 .. 25.6t5.90 * • 35.2^3.43 . , 41.9
£ 0.99
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renals they were 417*0 1 75,30 mg/LOO g. and 413*1 1 63,65 mg/lQO g.;
for the pancreas they were 12,5 - 1*57 ag/lQQ g, and 12.3 1 1.31 og/100
g.; and for the spleen they were 23,6 1 5*90 rag/100 g. and 27.3 1 6.91
.ag/lQO g. respectively. The TASA values obtained by the two phenyl-
hydrazine methods, in the liver, kidney and pancreas, are very close.
The liver contained 31.9 - 4*33 ag.TASA/LOO g. by the Roe and Kuether
method and 31.7 t 4*21 mg.TASA/LQO g. by toe Bolin and Book method. The
kidney contained 14*4 1 1*30 mg/lOQ g» by the first method, the corresp¬
onding figure in the second method being 14*0 1 1.27 mg/LOG g.; while in
the pancreas the figures wore 12.7 - 0.99 ag/100 g. and 13.2 1 0.96 mg/
100 g. respectively. A comparison of the ASA values and TASA values in
the liver, kidney and pancreas shows that there is very little difference
betweon the two values, though the TASA values are slightly higher. It
will be seen in some of the estimations, that toe ASA value has exceeded
the TASA value. The differences, observed here and in other experiments
to be described later, are not explicable on the basis of experimental
errors alone. It seems that some, but not all tissues must contain
significant quantities of material which interferes with the analytical
methods employed. The exact cause of this anomaly could not, however, be
ascertained. In the suprarenals, the TASA value obtained by the Roe and
Kuether method, namely 393*3 1 33,39 mg. TASA/l00 g. is lower than toe
ASA values (417.0 - 75.30 ag/LGO g. and 413*1 1 63.65 ag/100 g.) and the
TASA value of 423.4 1 75.36 mg/lOQ g. obtained by toe Bolin and Book
method
Table 2
Concentrations of ascorbic acid and total ascorbic acid in the tissues


























































































18,5 17.1 35.4 37.7








aathod. In the case of the spleen, the TASA value of 41.9 1 3.56 rag/lQO
g* obtained by the Roe and Kuether method is higher than 35.2 1 3*A3 mg/
100 g. obtained by the Bolin and Book method.
In Table 2, the results obtained in 8 female rats with a mean
body weight of 166 g. (range 140 to 190 g.) are shown. The tissues exam¬
ined were the liver, kidney, suprarenale, spleen, pancreas, brain and
voluntary muscle. Most of these data were obtained at the preliminary
stages of the investigation and the anomaly, referred to above, is more
apparent here and as such had led to the adoption of the different methods
of estimation. In the liver the ASA value by the indophenol method using
unbuffered extracts was 21.5 £ 4.69 rag/100 g. while the TASA value by the
Roe and Kuether procedure was 23.9 £ 2.21 mg/LOO g. In the suprarenals,
the corresponding figures for ASA and TASA were 394- 9 mg,/l00 g. and
380.6 rag/lOQ g. respectively. It will be noted that the TASA values in
the cases of fee kidney of 10.6 £ 1.87 mg/lGO g., pancreas of 7.1 mg/lOG
g, and muscle of 3.2 rag/LQQ g. are all lower than the corresponding ASA
values in the kidney of 12.0 £ 2.73 mg/XOO g., pancreas of 9.4 rag/!00 8*
and ismsele of 4.2 mg/LQO g. Tho TASA values in fee spleen and brain were
32.4 rng/lOO g. and 45.0 mg/100 g. respectively and these are higher than
the corresponding ASA values of 21.8 mg/100 g. in fee spleen and 17.7 mg/
100 g, in the brain.
On comparison of the ascorbic acid contents of the organs in the
two sexes, it will be observed that the male rats have a higher ascorbic
acid/
Ta^e g.
Concentrations of ascorbic acid and total ascorbic acid in the tissues of adult
sale rats, sacrificed by stunning.
Weight Tissue Indophenol method Roe & Kuethor
in g. method without method
buffered extract
mg.ASAAOO g. rag.TASA/LOQ g.














Mean 443*3 ..... 472.8
Tab!?
The distribution of ascorbic acid in the tissues of the albino rat ftosa Ifcerature
in milligrams per 100 g,of tissue.
(Figaros for control values, converted to lOQg. in some eases)*
No. .eight Sex Liver Kidney Supra¬
renal







27.0 17.0 36.0 6.0 Indophenol (77)
1 year old 17.0 14.0 37.0 4.0 u




































(v®)0.72*0.017 Roe & Kuether
(PI) 0.37t0.028 Indophenol
(W8) 0.35-0.011 Roe & Kuether
(PI) 0.33-0.019 Indophanol
(35)
7 200-250 g. male 362.6*20.4 37.0*1.9 Roe & Kuethor (32)
























female 23.912.21 10.61l.i7 330.6 32.4 3.2 7.1
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concentration in the liver, .ddneys, pancreas and the spleen. During
the course of the study, it was found that the male rats, in the range
of body weight used in this investigation, generally gained weight more
rapidly than the female rats. To settle this point whether different
rates of growth were responsible for the differences in ascorbic acid
concentrations, analyses were made of the organs of male rats of high
body weights and the results obtained are summarised in Table 3. These
animals were found to contain 21.3 fflg* as ASA and 23.1 iag. as TASA per
100 g. in the liver, 3.5 ag. as ASA and 10.1 mg. as TASA in the kidney
and 443*3 mg. ASA and 472.3 rag. TASA in the suprarenale; these values
agree well with the corresponding values in the female rats in Table 2.
Table 4 has been compiled from the literature and shows the con¬
centrations of ascorbic acid reported in the organs and blood of the
albino rats. These animals were used as control animals in the various
investigations. The relevant details of sex, age and weight, where
available, have been mentioned together with the method of estimation
used. The Table requires no detailed comment. In general it shows that
the concentrations of ASA previously reported in various rat tissues are
of the 3arae order of magnitude as those found in the present study.
The description of the results in the following pages is mainly
based on the ASA values obtained by the indophenol method using buffered
tissue extracts and TASA values obtained by the Roe and Kuether method.
The variations from this practice are duly pointed out.
The/
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The effects on the tissue concentrations of ascorbic acid following
nembutal anaesthesia are summarised in Tables 5 and 6. These animals were
sacrificed within 10 to 25 minutes after the administration of nembutal.
It will be observed, that in the male rats in Table 5, the liver was found
to contain 32.6 f 2.57 mg.ASA/LOO g. and 35.2 * 2.63 mg.TASA/lOO g. The
kidneys contained 15.6 - 2.94- rag.ASA/1CD g. and 21.1 — 4.59 mg.TASA/LOO g.
These values appear to be slightly higher than those in the previous control
group but the differences are not statistically significant. In the female
rats in Table 6, the liver contained 19.5 ~ 3* 22 rag.ASA/LOO g. and 22.9 -
3.29 sg.TASA/LOO g., the figures for the kidney being 9.6 - 1.43 mg.ASA and
12.5 i" 2.43 mg.TASA per 100 g. These values appear to bo similar to those
in the previous control group. It will be noted, however, that the TASA
value in the kidney has increased and the anomaly described before is less
apparent. In the male rata, the values for the suprarenals were 362.0 —
72.65 mg.ASA and 363.6 ~£ 36.94 mg.TASA per 100 g. (figures slightly but not
significantly lower than in the unanaesthetised animals), while the corresp¬
onding figures in the female woro 272.0 t 72.22 and 273.3 - 63.00 per 100 g.
(these figures appear to be definitely low when compared with the normal
levels). In the pancreas, in both groups, and in the spleen and brain in
the female rat the ascorbic acid concentrations are well within the normal
levels. Reference will be xaade to these minor variations in due course.
The results obtained fallowing trie intravenous injection of an ether-
extracted solution of hydroquinone to female rats on three successive days
and/
Tab}? g.
Coneantrations of ascorbic acid and total ascorbic acid in the tissues of




























1 160 Liver 29.7 29.3 32.7 35.5
2 150 35.5 35.5 32.6 37.0
3 160 33.2 32.1 33.2 33.1
4 170 33.6 34.2 33.9 34.9
5 155 35.5 34.7 37.5 39.1
6 160 29.9 29.4 27.9 31.3
Mean 159 Mean 32.9 i 2.53 32.6i2.57 33.0i3.07 35.2±2.63
Kidney 14.9 13.5 13.5 19.1
21.9 20.1 24.0 25.5
17.3 16.7 19.0 21.3
17.3 16.5 20.3 22.3
13.5 15.5 21.0 24.9
13.2 11.5 12.1 13.0
Mean 17.3i3.01 15.6+2.94 19.2+3.96 21.1+4.59
1 Adrenal 335.7 357.1 335.7 333.5
3 * 473.6 435.7 471.4 420.0
4 230.0 340.0 320.0 334.4
5 333.5 296.2 323.1 366.7
6 346.2 330.3 330.3 333.3
Mean 355.3 362.0 366.2 363.6
+73.52 +72.65 +64.60 +36.94
1 Pancreas 3.6 3.7 10.3 9.4
3 11.3 3.6 9.2 8.2
4 11.6 13.3 13.9 14.1
5 11.9 9.2 10.0 11.0
6 9.0 7.2 7.5 6.6
ifean 10.5*2.30 9.4*2.29 10.2+2.34 9.9*2.36
TabJ.e, , 6.
Gconcentrations of ascorbic acM and total ascorbic acid in the tissues of

































Liver 22.6 19.1 23.3 22.1
21.4 19.1 22.3 22.3
17.6 16.0 21.2 20.2 0,
18.7 17.5 20.0 19.5
25.1 25.4 27.5 23.6
23.1 20.1 24.3
Mean 21.412.32 . . 19.513.22 . . 23.012.90,,.22.913.29
Kidney 12.1 3.7 14.5 13.3
13.1 10.1 13.3 15.0
10.6 7.2 9.5 3.3
13.2 11.2 12.3 11.2
13.6 10.5 14.6 14.7
12.6 9.8 14.5 11.3
Mean 12.5*1.06 .. 9.6*1.43.. 13.2*2.01., 12.5*2.43
Adrenal 209.3 200.0 174.1 245.2
254.2 254.2 250.0 206.3
255.0 310.0 290.0 229.2
390.5 392.9 419.1 331.8
209.5 204.3 223.6 245.7
255.0 270.0 365.0 331.3
Mean 262.3*66.64 272.0172.22 231.ll85.12 273.3*63.00
•? ; 4! "
Pancreas 6*4 5.5 7.5 7.0
3.4 9.1 8.9 9.5
5.9 ««• 6.6 5.3
3.5 7.9 7.4 6.6
8.0 7.1 3.9 9.2
Mean 7.4*1.21 7.4 7.9*1.01 7.5*1.79
Spleen 11.9 10.1 27.3 30.2
24.4 22.5 39.5 -
17.2 13.0 31.9 33.2
14-4 13.1 31.3 33.1
Moan 17.0 . . . 16.0 . . . 32.6 • • <. 33.8
Brain 47.5 46.7 53.0 45.3
Tabl? 7
Concentrations of ascorbic acid and total ascorbic acid in the tissues of
the control female rats, injected with hydroquinone solution.
Mo. Weight Tissue Indophenol method Roe & Kuether Blood Sugar
in g. without buffered method
extract
agASA/LOO g» mgTASA/LOOg. mg/l00 ml.
1 155 Liver 22.2 25.0 124
2 150 19.0 24>«0 114
4 160 25.1 30.2 110
6 145 24.2 23.6 113
Mean . . 22.6 ... . . . 27.0
1 Kidney 16.0 16.1
A 17.6 15.4
6 15.3 16.4













and sacrificed under nembutal anaesthesia, are summarised in Table 7. The
tissues e:<amined were the liver, kidney, suprarenale and voluntary muscle.
In these experiments, the indoplienol method, using unbuffered extracts, was
used for the ASA estimations while the TASA concentrations were estimated
by tiie Hoc and Kuether procedure. The suprarenal glands from three animals
were pooled for analysis, in these experiments. It will be observed that
in the liver there was 22.6 mg.ASA/100 g. and 27.0 mg.TASA/lOO g. and these
correspond closely to the control values. In the kidney the ASA concentrat¬
ion was 16.5 rag.A00 S* and the TASA concentration was 16.0 rag/100 8* J these
values are slightly higher than the controls. The suprarenal glands wero
found to contain 287,2 rag.ASA/100 S* and 317.1 rag.TASA/LOO g. These values
are slightly below the controls. Those minor variat ions do not materially
affect the results of this investigation.
The results suamarised in Tables 8 and 9 show the immediate effects on
the concentrations following the intravenous administration of a single dose
of 0.7 g/Kg. body weight of DHA to the male and female rats. It will be
noted that the greatest concentration of TASA has taken place in the kidneys,
the figures being 487,6 mg/LOO g. in the male and 693*4 lag/LOO g, in the
feraale rats. The concentration of TASA has increased in the other organs in
the following order namely liver, pancreas and spleen* The liver was found
to contain 308.2 rag.TASAA00 g# in the male and 394*4 mg.A00 S» in the
female. These values represent a 10 to 16 fold increase above the original
levels. Of this amount in the liver in both sexes, about 82 per cent was
present/
Concentrations of ascorbic acid and total ascorbic acid in the tissues of the male
rats injected with dehvdroascorbic acid (0,2g. and 0.7g. per Kg. body weight approx.)<
Tissues removed after 15 minutes from the completion of the injection.
No. Weight Tissue Indophenol Indophonol Bolin & Roe & Whole
in g. method with¬ method Book Kuether Blood
out buffered with buff- method method (R & K)*
extmet extract ragCASA/ mgTASA/ §<
mgASA/LOQg. mgASA/LQQg. IQOg. lOOg, 100ml.
1 160 Liver 231.7 242.2 260.6 240.4 100.3
2 165 227.6 246,1 264.6 302.0 31.0
3 165 259.5 269.6 334.5 332.1 106.0
Mean. • 239.6 . . . 252.6 . . . 236.6 . ♦ 3°§-2
Reduction ... . 32%
1 Kidney 237.2 236.5 433.4 501.0
2 270,0 271.5 461.9 433.6
3 276.9 233.4 443.7 473.3
Mean 273.0 . , . 230,5 . . . 463.0 . , 437.6
Reduction . . . . 57%
1 Supra¬ 233.3 216.7 291.7 225.0
2 renal 250.0 240.0 273.3 234.2
3 253.3 273.3 273.3 256.7
Mean 262,2 . , * 243.3 « « , 279.4 . . 233.6
Pancreas 47.5 43.3 73.1 69.9
32.5 32.1 57.0 61.2
57.3 56.6 119.9 ia.2
Mean 45.9 . . . 45.7 , . . 33.3 . . 34.1
Reduction . . . . 54#
Spleen 155.1 153.9 133.1 160.6
79.1 34.6 109.1 117.9
91.3 39.3 114*4 114.0
Mean 103.5 . . , 111.1 , , . 135.5 , . 130.3
Reduction 82%
«3k>e & Kuether method.
Xg&a 9*
Concentrations of ascorbic acid and total ascorbic acid in the tissues of
female rats injected with dehydroa3corbic acid (0.2g. and 0.7g. per Kg, body
weight). Tissues removed after 15 minutes from the completion of injection.
Body weight Tissue Indophenol Indophenol Bolin & Roe & Whole
Initial Final method with¬ method Book Kuether Blood
g. S* out buffered with buff- method method (R & K)*
extract extract ragTASA/ ragTASA/ ragTASA/
ragASA/LOQg. agASA/1GQg. IQQg. lQOg. 100ml.
160 150 Liver 317.5 320.6 336.0 417.6 105.5
160 14B 313.7 306.5 344.3 369.1 90.5
163 152 363.6 352.3 370.1 396.5 114.0
Mean 331*6 ... . 326.6 ... 350.3 .. . 394-4
Reduction . . . . 33%
Kidney 336.0 351.7 643.5 655.7
321.2 307.4 664.6 630.1
4-05.2 373.0 730.6 744.5
Mean 354*1 * « • • 345.7 ... 679.6 .. . 693.4
Reduction . . . . 50%
Supra¬ 266.7 225.0 300.0 302.2
renal 309.6 294-2 321.2 316.7
334*3 326.1 373.9 311.9




44.6 42.4 69.5 62.7
51.4 47.5 37.3 34.6
Mean 46.1 ... . 42* 2 ... 76.2 .. . 70.5
Reduction • . . , 59$
Spleen 65.3 65.3 33.0 93.1
70.1 67.5 100.3 111.6
60.1 49.7 75.4
Mean 65.2 . . . . 60.3 ... 37.9 .. . 104.9
Reduction .... 58%
Hoe & Kuether method.
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pro3out as reduced ASA, the values being 252.6 mg.ASA/LOO g. and 326.6 rag./
100 g. in the male and female rats respectively. In the kidneya, the con¬
centration of TASA has increased approximately 32 time3 the normal level in
the male while the concentration in the female rat is about 63 times the
original level. Of this quantity, only about 50 per cent was present as
reduced ASA, the values being 230.5 rag.ASA/lOO g. in the male and 34-5.7 ag.ASA/
100 g. in the female. The concentration of TASA in the pancreas has risen
about sevenfold in the male, the value being 34.1 mg.TASA/LOG g., while in
the female, the value of 70.5 mg.TASA/lOQ g. represents a tenfold rise
approximately. Of this amount in the pancreas, about 50 per cent was found
a3 reduced ASA. The male pancreas was found to contain 45.7 rag.ASA/LOO g.
while the female pancreas contained 42.2 mg.ASA/lQQ g. In the spleen,
there has taken place a fourfold rise in TASA approximately. In the male,
of the TASA of 130.3 mg./lOQ g. about 32 per cent, tiiat is 111.1 mg./LOO g.
was present as reduced ASA, while the corresponding figures for spleen in
the female of TASA and ASA were 104.9 rag.TASA/lOO g. and 60.3 mg.ASA/lOO g.
respectively, which denotes about 53 per cent reduction. The concentration
of TASA in blood under the same conditions was in the neighbourhood of 100
rag./100 ml. The suprarenals of the male rats were found to contain 243.3
mg.ASA and 233.6 mg.TASA per 100 g., the corresponding figures for the
female rats being 231,8 mg.ASA and 310.3 mg.TASA per 100 g. Compared
with the normals, which were 417.0 k 75.30 mg.ASA/lOG g. and 393.3 hz 33.39
rag.TASA/LOO g. in the male rat and 394*9 rag.ASA/lOO g. and 330.6 mg.TASA/
100 g,/
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1CXJ g. in the female rat, the concentrations of ASA and TASA in the supra-
renal3, instead of showing an increase following the injection, seem to
have decreased. These figures indicate the extreme rapidity 'with which
the injected DHA is reduced to ASA; in 30 minutes, over three quarters
of an enormous dose of DHA has been reduced. The kidney is outstanding
in containing the greatest proportion of DHA; it seems possible that the
renal tissue may, like the leucocytes, tend to oxidise ASA rather than to
reduce DHA. This possibility which might help to explain certain anomalies
in the excretion of ASA deserves further investigation. Another point
which deserves special notice is the decrease in the ASA concentration of
the adrenals. This may indicate a 3tress reaction sufficiently powerful
to bring about a disappearance of ASA faster than it can be replenished
even from the very high concentrations in the circulating plasma.
Following the administration of a single dose of DM, when the
animals were sacrificed after an interval of 24 hours, the concentrations
of ascorbic acid in the organs had changed and these results are summaris¬
ed in Tables 10 and 11. It will be observed that in liver, kidney, spleen
and brain, the concentrations are higher than normals in both sexe3. Thus,
the liver of male rats was found to contain 41.6 - 2.78 rag.ASA/100 g. and
47.6 t 4.46 mg.TASA/100 g. In the case of the kidney the figures were
23.3 - 5.59 rag.A3A/100 g. and 30.1 - 6.33 mg.TASA/LQQ g.j for spleen they
were 27.4 ag.ASA/100 g. and 49.9 ng.TASA/lOQ g. and brain contained 51.3
rag.ASA/LOO g. and 61. 2 rag.TASA/LOO g. In the female rats, the liver contain¬
ed/
Table XQ.
Concentrations of ascorbic acid and total ascorbic acid in the tissues of
the male rats injected once with dehyiroaexsorbic acid (0.2g. and 0.7g.
per Kg. body weight). Tissues removed after an interval of 24 hours.
Weight in g. Tissue Indophenol Indophenol Bolin & Roe & Whole
Initial Final aethod aethod Book Kuether Blood
without with aethod method
buffered buffered
extract extract ragTASA/ mgTASA/ ogTASA/
agASA/LOOg. mgASA/LOOg. lOOg. 10%. 100ml.
163 Liver 4-5.7 44.7 43.7 44*1
150 HO 41.0 33.4 41.7 50.9
150 146 39.5 37.9 41.4 42.5 1.91
150 142 43.5 42.6 45.2 51.3
150 144 44.2 42.8 39.7 44.2
160 H5 46.7 43.2 44* 0 52.2 1.5
Mean 43.4^2.75 .. 41.6i2.73 ..42.6i2.03,,.47.6i4* 46 1.705
Kidney 31.1 29.3 32.4 41.7
19.2 16.8 25.5 23.6
27.5 29.6 30.9 32,7
21.6 17.7 25.1 25.1
25.4 22.5 20.3 25.6
26.9 23.1 25.7 26.7
Moan 25.3H.29 .. 23.3i5.59 ..26.7i3.37,,.30.1±6.33
Supra¬ 500.0 453.3 515.4 463.3
renal 392.0 373.3 403.0 403.3
379.4 353.8 364.7 325.0
357.1 346.4 357.1 305.3
367.7 376.5 376.5 370.0
333.3 233.3 320.0 *
Moan 333.3i53.30..365.4355.04. 339.0±67.27..375.5±65.75
Pancreas 13.7 10.3 12.4 10.9
10.3 10.1 10.3 10.5
14.5 13.1 H.9 15.2
3.7 3.5 9.4 9.1
15.5 14.0 14.0 15.2
H.9 12.9 13.2 13.3
Mean 13.0*2.45 .. 11.6X2.11 ..12.5X1.33. .12.5X2.62
Spleen 20.3 20.6 36.0 42.3
35.2 35.2 51.9 55.8
24*6 24.4 42.9 51.1
29.5 29.5 42.1 50.4
Mean 27.5 . . . 49.9
Brain 57.9 51.3 55.7 61.2
Tabl9 31.
Concentrations of ascorbic acid ami total ascorbic acid in the tissues of the
female rats injected once with dohydroascorbic acid (0.2g. and 0.7g. per Kg.
body weight). Tissues removed after an interval of 24 hours.
Body Weight Tissue Xndophenol Indophenol Bolin & Roe & Whole
Initial Final method method Book Kuether Blood
g. g. without with method method R & K
buffered buffered method
extract extinct mgTASA/ mgTASA mgTASA/
mgASA/l(X0g. mgASA/lQOg, lOOg. lOOg. 100ml.
150 135 Liver 46.3 45.3 43.0 47.3 1.48
157 140 45.3 46.1 41.0 51.1 1.93
155 145 35.9 32.6 35.3 33.6
160 143 42.4 41.4 41.2 40.3
160 146 42.7 40.9 41.4 42.1
162 143 44.0 41.3 43.3 45.3
155 133 47.2 47.0 47.7 43.1
Mean. . 43*4—3»75 • «» 42.2i4> 37 . .. 42.6t4.33. .44.ot4.45...1.73
Kidney 23.6 22.5 24.6 27.9
31.4 30.4 36.2 35.3
19.9 19.2 21.9 21.2
19.7 13.5 22.1 21.9
19.9 17.9 22.5 23.3
26.6 25.7 26.6 26.3
23.7 26.6 29.5 29.3
Mean. . 24.3*4.75 . .. 23.0t4.76 . .. 26.215.21..26.6t5.00
Supra¬ 302.1 304.2 312.5 272.2
renal 345.3 370.3 341.7 421.1
395.3 337.5 375.0 366.7
352.0 324.0 356.0 337.6
304.4 330.4 303.7 265.0
236.0 230.0 300.0 293.4
332.5 340.0 337.5 325.0
Mean. .331.2i37.43. ..333.3t36.9Q. .. 333.1*27.35.. 326.6±55.09
Pancreas 10.6 10.4 11.5 11.3
11.9 12.3 12.1 11.3
3.1 7.1 3.3 3.4
3.0 7.1 3.6 7.9
5.5 5.3 7.4 6.7
Mean. .. 3.8±2.49 . ... 8.5*3.01 .... 9.7*2.02.. 9.2±2.22
Spleen 34.4 34.2 60.4 69.1
29.1 26.6 46.6 53.1
42.5 33.3 60.1 71.4
26.1 23.3 51.6 53.3
Mean. . 33.0 . . . . 32.0 . . a . 54.7 . . . 63.0
Brain 57.6 51.3 55.4 52.4
54.5 55.2 57.2 57$7
Mean. . 56.1 ... . 53.5 . . . . 56.3 » • . 55.1
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ed 4-2.2 i 4*37 mg.ASA/LOO g. and 44.3 ± 4*4-5 mg.TASA/lOO g. The figures
for tiae kidney were 23.0 ± 4*76 mg.ASA/lOO g. and 26.6 t 5.00 mg.TASA/lQQ
g.j for the brain they were 53.5 mg.ASA/lOQ g. and 55.1 mg.TASA/LOO g.
The ASA and TASA values in the spleen of the female rats were slightly
higher than in the male rats, the figures being 32.0 ag.ASA/100 g. and
63.0 mg.TASA/lOO g. The TASA concentrations of blood in both sexes were
higher than normals, the value being about 1.7 mg/lOO ml. In the pancreas
tiie ascorbic acid appeared to have returned to the normal levels in both
sexes. In the suprarenals the concentrations of ASA and TASA in the raale
rat were 365.4 ± 55.04 ag.ASA/LQO g. and 375.5 4 65.75 mg.TASA/lOO g.,
the corresponding values in the female rat being 333.3 1 36.90 mg.ASA/lOQ
g. and 326.6 ± 55.09 mg.TASA/LOQ S» The ascorbic acid concentr tions in
the suprarenals seem to have increased when compared with the previous
groups in Tables 3 and 9 but are still below the normal levels. It appears
that most of the ascorbic acid introduced into the system lias been disposed
of during the 24 hours following the injection (vide Table 17).
The changes brought about in the animals injected with DfIA on two
successive days and sacrificed after an interval of 24 hours, aro shown in
Tables 12 and 13. Apart from slight variations in the individual organs,
the general picture of the heightened concentration of ascorbic acid, as
observed in the previous group of experiments, is still apparent. In the
male rats the liver contained 50.0 og.ASA/lOO g. and 53,0 mg.TASA/lOO g.
These are slightly higher than those in the previous group. The kidneys
contained/
Concentrations of aseorbie acid and total ascorbic acid in the tissues of the sale rats following two injections of
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Concentrations of ascorbic acid and total ascorbic acid in the tissues of the fesaalo rats following two injections








Tissue Indophenoi Indophanol Bolin & Book Roe &




ag&SA/LGOg. ngASA/lOQg. agTASA/lOug. mgrASA/1OOg.
Liver 42.1 40.5 39.2 35.9
41.2 39.7 33.6 41.9
Mean » 41.7 ... 40.1 ... 33.9 ... 33.9
Kidney 29.3 23.2 23.7 25.4
21.7 19.5 20.0 19.3
Mean 25.5 . . . 21*4 ... 21.9 ... 22.4
Supra¬ 455.2 443.3 465.5 433.8
renal 307.1 271.4 360.7 357.4
Mean 331.2 . . . 359.9 . . . 413.1 . . . 394.1
Pancreas 11.2 3.7 9.5 8.4
10.9 9.4 10.1 9.9
Mean 11.1 ... 9»1 ... 9.3 ... 9.2
Spleen 36.3 90.3 79.9
69.866.9 60.7 77.0












contained 26.7 mg.ASA and 29.6 rag.TASA per 100 g., in the pancreas the
values were 13.3 nig.ASA and 14.4- mg.TASA per 100 g. The spleen in these
»
. 1 ' . • , . '
animal3 shoved a marked increase in ascorbic acid concentrations, fee
values being 65.5 sag.ASA and 30.5 mg.TASA por 100 g. (by the Bolin and
Book method). However, in the female rats, a tendency towards a decrease
in concentrations in the liver and kidney is noticeable. The liver of
the female rats contained 4&.1 mg.ASA/100 g. and 33.9 mg.TASA/lOQ g.,
the values in the kidney being 21.4 mg.ASA and 22.4 nig.TASA per 100 g.
The concentrations in the suprarenals have increased slightly beyond the
normal levels. The suprarenal in the male rat contained 423.5 mg.ASA and
457.7 mg.TASA per 100 g., the corresponding figures for the female being
359.9 mg.ASA and 394*1 mg.TASA per 100 g. The values in the pancreas
were 9.1 rag.A3A and 9.2 rag.TASA per 100 g., while in fee spleen they were
75.5 mg.ASA and 73.5 mg.TASA per 100 g. (Bolin and Book method). The
blood TASA was still maintained at a high level. The blood sugar was
estimated in these animals at the time of sacrifice. Of the four animal3,
ono was definitely hyperglycaemic with a blood sugar of 233 rag/LQO ml.
while two others had slightly high sugar levels in blood (vide Table 17).
A remarkable feature of these results is the fact that there has not been
a marked change in the concentrations of ascorbic acid in the tissues
following the second doso. Possibly in the meantime, the mechanism of
disposal has become too efficient to deal wife fee extra amount of ascorbic
acid that was introduced.
Table/
-41-
Table 14. summarises the results obtained in acute experiments in
female rats following the third injection of DM. In these experiments,
the ASA concentrations were estimated by the indophenol method using un¬
buffered extracts while the TASA values were obtained by the Hoe and
Kuether method. The suprarenal glands, however, were pooled and analysed.
Some of the TASA values in these estimations, in the liver especially, are
lower than the ASA values, possibly due to interference in the methods.
Following the injection it will be noted that a rise in the ascorbic acid
(ASA + TASA) concentrations has taken place (Cf. Table 9)* Of the TASA
concentrations of 273.3 mg./LQO g. in the liver and 657.1 mg./lQO g. in
the kidney, there was complete reduction in the liver, whereas in the
kidney the reduction was about 50 per cent as before, the value being
328.3 mg.ASA/LQO g. In the voluntary muscle of the TASA concentration of
27.8 rag/lOQ g», the ASA was 15.5 rag./100 g. representing about 50 per cent
reduction. The concentrations in the suprarenala of ASA ware 396.5 mg/LOQ
g. and TASA, 363.1 ag/lOO g. These figures are not significantly higher
than normal. The blood sugar was estimated immediately before the injact¬
ion of DM in these animals. Hyperglycaemia wa3 present in all of them
except two. Mention must be made of the fact that the tissues have retain¬
ed the potior of reducing, and doing that with extreme rapidity, even though
they had been subjected to so much strain in the meanwhile.
The results of the chronic experiments following the three injections
















Concentrations of ascorbic acid and total ascorbic acid in the tissues
of the female rats following three injections of dehydroascorbic acid.






















































































Concentrations of ascorbic acid and total ascorbic acid in the tissues of tho laale rat following












Indophenol Indaphonal Bolin & Roe & Whole Blood Day of
method method Book Kuether blood Sugar Sacrifj
without with method method R & K
buffered buffered method
extract extract n^TASA/ mgTASA/ mgTASA/ og/lOO
mgASA/LOOg. agflSA/iOGg. lOQg. lOOg. 100 nil. ml.
46.3 45.1 43.9 «■» «. 135 3th
33.3 39.4 37.5 36.3 0.62 119 3th
39.5 41.1 35.1 39.3 0.7 119 9th
50.7 45.2 43.3 40.4 0.7 162 10th
42.3 41.7 39.5 36.2 0.63 122 11th
35.2 34.2 34.5 33.9 0.73 155 15th
Kidney 29.5 23.5 27.7
16.3 16.4 17.3 17.0
20.3 20.1 19.7 20.1
22.4 20.6 23.3 23.2
22.9 21.9 21.6 19.7
16.6 16.3 13.8 17.6
Supra¬ 320.0 320.0 310.0
renal 400.0 435.0 405.0 411.1
334.2 400.0 342.1 359.4
375.0 407.5 370.0 396.1
435.0 430.0 450.0 420.6
423.3 439.1 395.2 367.5
Pancreas 15.2 15.0 14.7
3.9 9.7 10.1 9.3
9.9 9.1 9.0 3.8
11.6 10.5 10.3 10.5
10.9 9.9 10.2 9.3
9.1 9.2 9.7 9.4
Spleen 31.0 29.2 39.3
25.2 23.5 35.1 41.0
43.9 45.3 49.0 49.2
45.5 33.6 45.5 41.5
29.0 27.5 34.4 36.9
30.0 23.0 39.3 45.9
Table 16
Concentrations of ascorbic acid and total ascorbic acid in the tissues of the female rats following three
injections of dehydroaacor'oic acid. Tissues removed after an interval of 8 days or more.
No. Animal Weight Tissue Indophenal Indophenol Bolin & Book Roe & Whole Blood Day of
Initial Final method method method Kuether Blood sugar sacrifice
g. g. without with method Roe &
buffered buffered Kuether
extract extract mgTASA/ m^FASA/ iag/
mg&SA/LOQg. mgASA/lOQg. rngTASA/LOCg. lOQg. 100ml. 100ml.
1 160 160 liver 24.7 22.1 24.7 29.9 0.44 96 3 days
2 150 138 25.2 22.2 24.6 23.6 0.45 333 3 days
3 150 137 17.9 15.5 17.4 13.2 399 10 days
Kidney 15.7 12.8 15.5 14*4
12.3 3.4 11.5 10.1
12.3 3.8 12.1 10.8
Supra- 400.0 400.0 430.0 425.0
renals 263.8 264.1 313.3 323.9
440.7 437.0 463.0 456.5
Pancreas 9.4 8.2 3.5 9.1
10.7 8.0 10.7 11. 3
9.4 9.6 10.5 9.5
Spleen 21.6 20.4 31.3 42.1
21.3 19.5 23.3 37.3
21.0 21.0 23.4 31.3
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animals were sacrificed after an interval of 8 days or more following
the last injection. It will be observed that the concentrations of
ascorbio acid in the tissues and blood have fallen and reached almost
the original levels. Thus in the male rat, sacrificed on the 3th day,
the liver was found to contain 36.3 ng.TASA/lOl g. (Roe and Suether
method) and the corresponding figures for the kidney, suprarenal, pancreas
and spleen in the same animal were 17.0 tag., 411*1 rag., 9.3 tag. and 41.0
nig.TASA per 100 g. respectively. Similarly in a female rat, the corresp¬
onding figures, for liver, kidney, suprarenal3, pancreas and spleen, were
29.9 mg,, 14*4. tag., 425.0 tag,, 9.1 rag. and 42.1 mg.TASA per 100 g. respect¬
ively. The blood TASA values in the above anioal3 wore 0.62 mg. and 0.44
mg. per 103 ml. The blood sugar was estimated at the time those animals
were sacrificed. Of the nine animals, two wore hyperglycaeoic with high
sugar values while threo others had slightly high sugar levels. From the
results, it appears that the organism has recovered or is recovering from
the strains to which the metabolism of ascorbic acid, in general, was
subjected.
In some of the experiments, already described (Tables 10 to 13, 15
and 16) following one, two and three injections of DM, the animals were
sacrificed after an interval of 24 hours or more. The changes in the
concentrations of ascorbic acid when compared with the normal control are
summarised in Table 17 for easy reference. Only the TASA values obtained
in the organs have been taken into account for the preparation of this
table./
Table 17.
Changes in tissue concentrations of ascorbic acid observed after
on interval following DHA injections.
Male Rats
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table. The differences between the mean values denote the changes brought
about in the concentrations.
In view of the observations made in the experiments with DHA, it
was of interest to know the immediate effects of ascorbic acid under
similar conditions. Ascorbic acid was dissolved in 0,9 par cent sodium
chloride solution in the proportions used for the preparation of DHA and
was injected intravenously to rats starved for 24 hours. As in the exper¬
iments with DHA, a preliminary dose of 0,2 g/Xg. followed by another dose
of 0,7 g/Kg. body weight of ascorbic acid was administered. Previous to
the larger dose of ascorbic acid, nembutal in a dose of 6 rag/103 g, was
injected intrapcritoneally. Following the larger dose of ascorbic acid,
the animals were bled from the 10th to the 14th minute and tissues were
removed from the 15th to the 21st minute. A male and a female rat were
used for these experiments and the results obtained are summarised to¬
gether in Table 13. It will be observed that the values obtained by the
indophanol method in the cases of liver, suprarenale, pancreas and spleen
agree well with those obtained by the two phenylhydrasine methods. But
in the case of the kidneys the ASA values are much higher than the TASA
values obtained by the Roe and Kuether method. For the description of
results, the TASA values obtained by the Roe and Kuether method are being
considered. It will be noted tliat the greatest concentration of ascorbic
acid has taken place in the kidneys. Thus, in the male rat the kidney was
found to contain 624,6 mg.TASA/llX) g. This represented a rise of about 40
times/
Table 13,
Concentrations of ascorbic acid and total ascorbic acid in the tissues of a male
and a female rat injected with ascorbic acid (0.2g. and 0.7g, per Kg. body vrfc).
Tissues removed 15 minutes after the completion of the injection.





















































Pancreas 110.9 107.3 119.4 126.1









times the original level. The kidney in the female rat contained 651,6
tag«TASA/LOO g*, a value which was about 60 times the normal level. In
the liver, the male rat was found to contain 130*7 mg.TASA/lQG g, repros-
enting a fourfold rise and in the female a sevenfold increase had resulted
in a concentration of 163,1 mg.TASA/LOQ g. The pancreas in the male rat
had 126,1 mg.TASA/LOO g.j in the female it contained 142,5 iag,TASA/lOO g.
These represented a 10 to 16 fold rise from the original levels. The
concentrations in spleen had gone up two to threefold to reach the levels
of 34»2 mg.TASA/LQO g, in the male and 91,0 mg.TASA/LOO £• in the female
rat. The TASA levels in blood were 139,0 mg, and 162.0 mg, per 100 ml, in
the male and female respectively. The suprarenal in the male rat was found
to contain 326,5 mg.TASA/LQQ g,, the corresponding figure in the female was
352,5 mg.TASA/LOO g. When these figures are compared with the normals
they appear to be low. When the results obtained in the acute experiments
with DIIA in Tables o and 9 are compared with those above, the following
features are noticeable. Following the ascorbic acid injection, a greater
concentration of TASA has taken place in the blood. The coneentratione in
the pancreas are a little higher; they are approximately equal in both
cases in the kidney. The rise in concentrations in the liver and spleen
is less marked. The fall in the levels of ascorbic acid in the suprarenals
is less marked, but, since in other tissues an actual increase is found,
this is significantly outstanding behaviour; and it is presumably related




It may be important that ASA ia concentrated in tlie pancreas mesh
more efficiently than is DHA, while DHA ia more avidly taken up in the
liver, spleen and other tissues.
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DISCUSSlQN
The methods of estimation of ascorbic acid and total ascorbic acid
used in this investigation, namely the indophonol and the phenylhydrazlne
methods, are well known analytical procedures. From the results it appears
that, apart from experimental errors, the question of interference by some
metabolite or metabolites in one or the other or in both the methods cannot
be ruled out. Of the tissues e:<amined, the interference has been observed
most frequently in the liver, kidney, suprarenal3 and brain but not in all
at the same time. Each of those organs is of high metabolic activity.
The differences in the tissue concentrations of ascorbic acid observed
in the sexes of the control animals are most probably due to unequal rates
of growth in the male and female rat. In the range of body weight of the
rats used in this study, the male rat generally gained weight more rapidly.
Thus days and sometimes weeks passed before the female rats attained the
weight of the corresponding male rat. It may be recalled that in the control
animals the body weights were almost equal in the two sexes and as such the
female rats were relatively more mature than the male rats, Bessay and King
(77) observed that under Identical conditions of nutrition, the tissues of
the young and rapidly growing animals tend to have a higher vitamin C concen¬
tration. A few other observations in this connection deserve mention. Tod-
hunter and McMillan (85) demonstrated a significantly higher concentration
of ascorbic acid in plasma and blood of the adult male rat. Salhaniok,
Zarrcw/
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Zarrow and Zarrow (86) found an increase in ascorbic acid concentration of
the pituitary with increase in age in the female rat. Sutton, Kaeser and
Hansard (87) observed a sex difference in the rate of excretion of vitamin
C. The female rats excreted only about half as much as did the male rats.
k close relationship exists between growth and the metabolism of ascorbic
aoidj the disappearance of the vitamin is greater during periods of rapid
growth. Reid (38) observed in the guinea pig, that the younger the animal
and the more rapidly it grows, the smaller is the amount of vitamin C
excreted in the urine.
Following nembutal anaesthesia, in the rat, a depletion of adrenal
ascorbic acid takes place and simultaneously the ascorbic acid concentrat¬
ions in the liver and kidney rise, particularly in the male rat. This
observation is in line with a similar observation raade by Bowman and
following ether anaesthesia
Muntwyler (79) in. the albino rats. They reported that along with this
change in the coneentrations, there is increased excretion of ascorbic acid
in the urine of a short duration. Ludewig and Chamtin (89) observed a de¬
layed depletion of adrenal ascorbic acid following nembutal anaesthesia.
Recent observations, in man, have shown that the induction of general anaes¬
thesia with pentothal, cyclopropane and ether was associated with increased
levels of 17-hydro:ycorticosteroids in blood plasma (90). It appears that
this rise in concentration of 17-hydroxycorticostoroids in plasma is due
both to the increased secretion by the adrenal cortex and to the impaired
destruction in the liver temporarily (91). It is also known that conjugated
products/
-*4&-
products of l?-hydro:sycortico3ieroids are excretad in the urine in large
quantities under the above conditions# The relation of ascorbic acid to
this synthesis and destruction of corticosteroids is at present obscure.
Dehydroascarbio acid tends to diffuse readily into the liver,
spleen, pancreas, kidney, brain and muscle in the rat. It is reduced in
the liver to the extent of about 80 per cent within a short tins. Probably
liver is the site where most of the added dehy&roascorbic acid is reduced
and the study of the literature suggests the same. The amount of reduction
in tiie spleen is a little less, whereas in the pancreas, kidney and muscle
about half as much is reduced during the same period. Patterson et al. (51)
observed that, with gradual accumulation of reduced ascorbic acid, the rise
in the level in the brain tends to fall off. The dosage of dehydroascorbic
acid used in this investigation was very high, and it is conceivable that
the tissues were more or leas saturated with ascorbic acid from the reduction
of dehydroascorbic acid. The excess was circulating in the blood and was
being concentrated in the kidneys. The very high concentration in the
kidneys is probably an expression of this situation. It is also an attempt
on the part of the organism to throw out the excess in the urine before it
could bo converted to other metabolic products such as 00^ and others. During
the first 24 hours following the injection, most of the ascorbic acid intro¬
duced disappears and only a little remains. Following the second dose,
presumably there occurred a rise in the levels and the process of reduction
was repeated. At the end of 24 hours following this, a rise in the concen¬
tration/
—4.9—
tratioaa in the tissues above the levels obtained after the first dose was
expected. Such a rise wag not observed. Possibly in the meantime the
metabolic rate a3 a whole ha3 become geared to a high level and the organ¬
ism is too efficient in the disposal of the extra amount. Mien time is
allowed, the increased levels tend to return to their original values.
The mechanism of reduction almost certainly involves glutathione and
the cycle goes into action every tirao the dose is repeated. Borsook et al.
(19) from their studies concluded that glutathione is possibly the main
agent concerned in the reduction of dehydroascorbic acid in vitro and in
vivo. Schultze et al. (41) suggested that glutathione and fixed -SH compounds
are the gain agents responsible for the reduction of added deliydroascorbic
acid. It is interesting to note that their observation of a large excess of
ascorbic acid slowing down the rate of reduction of DHA jyn vitro bears a
similarity to the observation of Patterson jgt gl. (51) mentioned above.
(59)
Bhattacharya/nas demonstrated a fall in the glutathione concentration in the
rat liver along with reduction of dehydroascorbic acid, A significant change
in the concentrations of glutathione in the pancreas was not observed in that
investigation. Suggestive evidences of reduction with consequent damage to
the islet-calls have been put forward by Patterson and Laaarow (64) snd
Bhattacharya (59).
From the data collected in these experiments it is not possible to
draw a complete picture of the fate of the injected dehydroascorbic acid.
From the observations it appears that major amounts of the injected dose
were/
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were reduced to ascorbic acid. Dehydroaseorbic acid is not stable at the
temperature and pH of the tissues for more than a few minutes and under¬
goes irreversible transformation to diketogulonic acid. Penney and Zilva,
(20) reported that, of the dehydroascorbic acid injected intramuscularly
into the guinea pig, about 25 per cent was excreted as diketogulonic acid
during the next 24. hours, mostly during the first 3 or 4 hours. Some of
the injected dehydroascorbic acid in these rats must have been excreted
in this way. Burns et al. (25), from their tracer studies with labelled
ascorbic acid, concluded that, of the amount synthesized in the normal rat,
only about 15 per cent was excreted in the urine during the 24 hours. In
a rat, stimulated to synthesize ascorbic acid with chlaretone, as much as
43 per cent could be excreted. They found that significant amounts were
converted to CO2 and expired. In the urine appreciable quantities of
oxalate './ere present besides ascorbic acid, dehydroascorbic acid, diketo¬
gulonic acid and other unidentified products. In the present study possibly
the metabolic processes were enhanced, and large quantities of ascorbic acid
were disposed of in a manner analogous to the above. In 3one of the animals
dysenteric symptoms were noted. It might have been a result of increased
excretion through the gastrointestinal tract. Reid (92) reported that follow¬
ing intraperitoneal injection of ascorbic acid into guinea pigs the amount
of ascorbic acid excreted into the stomach and intestine was much more than
15 per cent of the injected dose.
The causation of diabetes appears to be incidental in the situation
brought/
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brought about by the exhibition of large amounts of dehydroascorbic acid.
It is doubtful whether a similar situation could occur naturally. Once
the organism has dealt with the situation, the metabolism of ascorbic acid
a3 a whole returns to normal. In the context of the picture drawn above,
the observation of diketogulonic acid in blood in human diabetes (93) does
not fit in.
The role of the suprarenal gland in thin requires further study. The
observation;., made, suggest that intravenous injections of deiaydros.seorbic
acid or ascorbic acid, at the dosages used in this investigation, induce a
stressful condition and immediate depletion of ascorbic acid from the adrenal
gland ensues. The real mechanism of this depletion is not understood at
present. It is said that, most probably, ascorbic acid undergoes destruction
within tho gland. It Is reasonable to assume that the concentration of
ascorbic acid inside the gland falls. Even with this reduced concentration
inside the gland, the dehydroascorbic acid or ascorbic acid, injected and
present in high concentration in the blood outside, does not seem to diffuse
into the gland, at least at a sufficient rate to replace completely the amount
metabolised. The suggestion of Patterson and Mastin (51) that ascorbic acid
must be oxidised to dehydroaacorbic acid before it penetrates the cell membrane
does not seem to hold good in this instance. The subsequent events in the
suprarenals follow the pattern of events in stress. The adrenal ascorbic acid
tends to rise and tho weight of the gland increases (vide appendix). Bury
(94-) observed a significant rise in adrenal ascorbic acid 65 hours after alloxan
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injection together with an increase in the weight of the adrenal glands in
the albino rat. These observations are strongly suggestive of the fact that
the phenomenon of stress plays a great role at the initial stages following
the injections of these diabetogenic substances. Once we accept that this
is so, tile chain of reactions set in motion becomes too complex to visualise.
Dehydroascorbie acid and alloxan both show the triphasic response in the
blood sugar, hyperglycemia, hypoglycemia and hyperglycemia. The sequence
of events, in terms of stress, would appear to be as follows
Stress—> hyperglycemia due to
adrenocortical causes
(? Role of Pituitary)
—> hypoglycemia
—»hyperglycemia, possibly
due to the failure of
the pancreas to elaborate
insulin.
Transient hyperglycemia following DKA. injection is possibly mainly due to
adrenocortical/
•wgjh1
adrenocortical causes. Garey, Vollmer, Zweaer and Spence (95) observed a
fall in the adrenal ascorbic acid and cholesterol concentrations, following
subcutaneous or intraperitoneal injections of glutathione in large doses in
rats and guinea pigs. It has been observed that following intravenous inject¬
ion of ascorbic acid, there is a fall in the adrenal ascorbic acid concentrat¬
ion. It has been claimed that ascorbic acid potentiates the diabetogenic
effect of alloxan. Levey and Suter (96) expressly stated that for this
potentiation to occur, the intravenous injection of ascorbic acid should be
followed within a minute by alloxan. Patterson (61) observed a synergistic
action of dehydroascorbic acid or ascorbic acid with alloxan and the condit¬
ions, under which ho observed this synergism, were almost similar. The admin¬
istration of pituitary adrenocorbicotrophic hormone (ACTil) is followed by a
temporary decrease in the amount of ascorbic acid present in the adrenal
glands ( 31, 97). In the light of those evidences, the interpretation
of the observations made at the initial stages of the reaction becomes very
difficult. Sotae active agent or agents ("neuroimmour", hypothalamus) appear
to be involved in common with all these substances, at least at the initial
stages of tlie reaction.
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sB^amy ADD capuBjCffi?
Observations wore made on the ascorbic acid and "total ascorbic acid"
(ASA + DHA + DM) concentrations in the liver, kidney, pancreas, spleen,
suprarenale and other tissues before and after the intravenous injection
of dehydroascorbic acid in diabetogenic doses to the male and female
albino rats. The immediate effects following the intravenous injection
of ascorbic acid under similar conditions were also studied.
2. Immediately following the dose of dehydroascorbic acid the concentration
of total ascorbic acid rose most in the kidneys, where about a fiffcyfold
ri3© was noted. The concentrations rose in other tissues In the follow¬
ing way, liver (10-16 fold), pancreas (7-10 fold) and spleen (about four¬
fold). The dehydroascorbic acid that entered the tissues was rapidly
reduced. The extent of reduction in the liver was more than 30 per cent,
it was a little less in the spleen whereas in the kidneys and pancreas
about 50 per cent reduction took place. Twenty four hours later most of
the excess ascorbic acid had disappeared, though slightly high levels
were observed in some of the tissues, specially in the liver and kidneys.
Following the second dose, the concentrations in the tissues presumably
rose but at the end of twenty four hours further accumulation had not
taken place. Following the third dose reduction to ascorbic acid was
observed to take place. The concentrations in the tissues were almost
normal eight days later.
2-/
65"
2* Compared to dehydroascorbic acid, the administration of ascorbic acid
under similar conditions led to a greater rise in the concentrations
in the pancreas; the kidneys concentrated to the same extent as before
whereas the liver and spleen concentrated much less.
After preliminary desenaitisation, the intravenous injection of 0.7 gAg
of dehydroascorbic acid caused an immediate depletion of adrenal ascorbic
acid. The administration of ascorbio acid under similar conditions
resulted in depletion of adrenal ascorbic acid as well. The fall was
more marked after dehydroascorbic acid and in the male rat. Twenty four
hours later a restoration in concentration of adrenal ascorbic acid
occured together with a significant rise in adrenal weight.
The relationship between the causation of experimental diabetes and
ascorbic acid metabolism in general is discussod. After the onset of
experimental diabetes the ascorbic acid metabolism is not necessarily
deranged. The role of the suprarenal glands and the phenomenon of




The weights of the adrenal glands obtained from the animals used in
the different groups of experiments described in the text are summarised in
Tables 19 and 20, In Groups A in the tables are placed, the control animals
which were sacrificed by stunning. The moan 2S.D. of the adrenal (rag/100 g.
body weight) in the male animals were 19,5 - 2.03 mg., the corresponding
figure in the females was 26,6 i" 5.12 ag. The Groups B show the control
animals sacrificed tinder nembutal anaesthesia. The corresponding figures,
as above, were 18.1 - 1.04 ag, in the male and 28.6 "i 2.40 mg. in the female.
In Groups G, D and E are the animals which wore starved for 24 hours prep¬
aratory to the injection experiments. Groups C show the animals used in the
acute experiments with DHA and ASA. The moan iS.B. of the adrenal weights
(rng/LOO g. body weight after starvation) were, in the male 21.3 1.52 mg.
and 32.3 "3: 2,87 mg. in the female. In Groups D are summarised the adrenal
weights of ttie animals sacrificed after an interval of 24 hours, following
the injection of DI3A. The means iS.D. of the adrenal weight (mg/lGO g. final
body weight) were 24.2 "i 1.92 mg* and 36.7 "± 2.90 rag. in the male and female rats
respectively. Statistical analyses of the data in Groups C and D show that
the weights of the adrenal glands in Group D are significantly higher than
the weights in Group C (P lies between 0.05 and 0.02 in both sexes). The
animals sacrificed after 24 hours following two injections of DIIA, as shown
in Groups E, had the mean adrenal weights of 30.6 mg. in fee male and 43.7 mg.
in/
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in the female rat3 respectively. The values are higher than those corresp¬
onding in Groups D. It i3 much regretted that the significance of the find¬
ings were realised late in 'the investigation and much material had been lost
in the meantime*
Table 19.
Variations in the weights of adrenal glands in the male rat.
Groups Body weight Adrenal weight Adrenal weight Adrenal weight
in g. in rag. 10%. initial Xv*t. 100g. final wt.
Initial Final
A. 165 32 19.4
163 23 17.2
Control animals 165 31 13.3 -
sacrificed by 170 37 22.9
stunning 160 33 20.6
155 23 18.1
Mean .... 19.5 t 2.03
B. 160 27 16.9
150 30 20.0
Control animals 160 29 13.1
sacrificed under 170 31 13.2
nembutal anaesth¬ 155 23 18.1
esia 160 23 17.5
Mean .... 13.1 I 1.04
C. 160 145 23 17.5 19.3
Animals used for 165 160 34 20.6 21.3
acute experiments 160 140 30 13.3 21*4
with DM and ASA 172 165 33 22.1 23.0
Mean ...» 19.75 i 2.02 21.3
163 29 17.3
23.6D. 150 140 33 22.0
150 146 39 26.0 26.7
Animals injected 150 142 33 22.0 23.2
with DM once and 150 144 37 24.7 25.7
sacrificed 24 hrs. 160 150 33 20.6 22.0
later. Mean .... 22.1 t 3.03 , . 24.2
E. 160 132 34 21.3 25.3
Animals injected 160 130 46 23.3 35*4




Variations in the weight of adrenal glands in the female rat.
Groups Body weight Adrenal weight Adrenal weight Adrenal weight
in g. in mg. IGOg. initial wt. 100g» final wt.
Initial Final
A. 150 39 26.0
140 26 18.6
Control animals 173 43 30.0
sacrificed by 175 42 24.0
stunning 160 44 27.5
155 52 33.5













Mean ... 28.6 * 2.40
C. 160 150 47 29.4 31.3
160 148 50 31.3 33.3
Animals used for 163 152 44 27.0 23.9
acute experiments 150 141 44 29.3 31.2
with DHA and ASA 155 140 51 32.9 36.4
Mean ... 30.0 1 2.24 * . 32.3
D. 150 135 51 34.0 37.3
157 140 43 27.4 30.7
Animals injected 155 145 54 34.3 37.2
with DHA once 160 143 53 36.3 39.2
and sacrificed 160 146 53 33.1 36.3
24 hours later. 162 143 56 34* a 39.2
155 133 50 32.3 36.2
Mean . . . 33.2 1 2.36 . . 36.7
E. 155 135 68 43.9 50.4
Animals injected 160 132 62 38.8 47.0
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